APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Aminoglycosides Antibiotics

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

Selected research

Market Analysis & Forecast

Global Aminoglycosides Antibiotics Market Analysis and Forecast 2026-2032

Report ID 173962830228 December 2025194 pages

Choose your research edition.

Industry ResearchAminoglycosides Antibiotics Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Aminoglycosides Antibiotics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Aminoglycosides Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aminoglycosides Antibiotics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Aminoglycosides Antibiotics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.

Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.

Read the full market overview

Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%.

Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.

This report presents an overview of global market for Aminoglycosides Antibiotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Aminoglycosides Antibiotics, also provides the sales of main regions and countries. Of the upcoming market potential for Aminoglycosides Antibiotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Aminoglycosides Antibiotics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Aminoglycosides Antibiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Aminoglycosides Antibiotics sales, projected growth trends, production technology, application and end-user industry.

Aminoglycosides Antibiotics Segment by Company

Jemicare

Teva

Novartis

Fangyuan-pharma

Aike Pharmaceutical

Cipla

Pfizer

Fresenius Kabi

Sun Pharma

Hikma

Lannett Company

Aminoglycosides Antibiotics Segment by Type

Neomycin

Tobramycin

Gentamicin

Amikacin

Etimicin

Others

Aminoglycosides Antibiotics Segment by Application

Hospital

Clinic

Post Care Facility

Government & Military

Others

Aminoglycosides Antibiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aminoglycosides Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aminoglycosides Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aminoglycosides Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Aminoglycosides Antibiotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Aminoglycosides Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aminoglycosides Antibiotics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Aminoglycosides Antibiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Neomycin Major Manufacturers Table 3. Tobramycin Major Manufacturers Table 4. Gentamicin Major Manufacturers Table 5. Amikacin Major Manufacturers Table 6. Etimicin Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Aminoglycosides Antibiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Major Manufacturers Table 10. Clinic Major Manufacturers Table 11. Post Care Facility Major Manufacturers Table 12. Government & Military Major Manufacturers Table 13. Others Major Manufacturers Table 14. Aminoglycosides Antibiotics Industry Trends Table 15. Aminoglycosides Antibiotics Industry Drivers Table 16. Aminoglycosides Antibiotics Industry Opportunities and Challenges Table 17. Aminoglycosides Antibiotics Industry Restraints Table 18. Global Aminoglycosides Antibiotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Aminoglycosides Antibiotics Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Aminoglycosides Antibiotics Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2021-2026) Table 22. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2027-2032) Table 23. Global Aminoglycosides Antibiotics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 24. Global Aminoglycosides Antibiotics Sales by Region (2021-2026) & (M Units) Table 25. Global Aminoglycosides Antibiotics Sales by Region (2027-2032) & (M Units) Table 26. Global Aminoglycosides Antibiotics Sales Market Share by Region (2021-2026) Table 27. Global Aminoglycosides Antibiotics Sales Market Share by Region (2027-2032) Table 28. Global Aminoglycosides Antibiotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Aminoglycosides Antibiotics Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Aminoglycosides Antibiotics Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Aminoglycosides Antibiotics Sales Market Share by Manufacturers (2021-2026) Table 32. Global Aminoglycosides Antibiotics Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 33. Global Aminoglycosides Antibiotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Aminoglycosides Antibiotics Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Aminoglycosides Antibiotics Manufacturers, Product Type & Application Table 36. Global Aminoglycosides Antibiotics Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Aminoglycosides Antibiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Aminoglycosides Antibiotics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Aminoglycosides Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Aminoglycosides Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2021-2026) Table 43. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2027-2032) Table 44. Global Aminoglycosides Antibiotics Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 45. Global Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 46. Global Aminoglycosides Antibiotics Sales by Type (2027-2032) & (M Units) Table 47. Global Aminoglycosides Antibiotics Sales Market Share by Type (2021-2026) Table 48. Global Aminoglycosides Antibiotics Sales Market Share by Type (2027-2032) Table 49. Global Aminoglycosides Antibiotics Price by Type (2021-2026) & (USD/Unit) Table 50. Global Aminoglycosides Antibiotics Price by Type (2027-2032) & (USD/Unit) Table 51. Global Aminoglycosides Antibiotics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Aminoglycosides Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Aminoglycosides Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2021-2026) Table 55. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2027-2032) Table 56. Global Aminoglycosides Antibiotics Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 57. Global Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 58. Global Aminoglycosides Antibiotics Sales by Application (2027-2032) & (M Units) Table 59. Global Aminoglycosides Antibiotics Sales Market Share by Application (2021-2026) Table 60. Global Aminoglycosides Antibiotics Sales Market Share by Application (2027-2032) Table 61. Global Aminoglycosides Antibiotics Price by Application (2021-2026) & (USD/Unit) Table 62. Global Aminoglycosides Antibiotics Price by Application (2027-2032) & (USD/Unit) Table 63. Jemicare Company Information Table 64. Jemicare Business Overview Table 65. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Jemicare Aminoglycosides Antibiotics Product Portfolio Table 67. Jemicare Recent Development Table 68. Teva Company Information Table 69. Teva Business Overview Table 70. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Teva Aminoglycosides Antibiotics Product Portfolio Table 72. Teva Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Novartis Aminoglycosides Antibiotics Product Portfolio Table 77. Novartis Recent Development Table 78. Fangyuan-pharma Company Information Table 79. Fangyuan-pharma Business Overview Table 80. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio Table 82. Fangyuan-pharma Recent Development Table 83. Aike Pharmaceutical Company Information Table 84. Aike Pharmaceutical Business Overview Table 85. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio Table 87. Aike Pharmaceutical Recent Development Table 88. Cipla Company Information Table 89. Cipla Business Overview Table 90. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Cipla Aminoglycosides Antibiotics Product Portfolio Table 92. Cipla Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Pfizer Aminoglycosides Antibiotics Product Portfolio Table 97. Pfizer Recent Development Table 98. Fresenius Kabi Company Information Table 99. Fresenius Kabi Business Overview Table 100. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio Table 102. Fresenius Kabi Recent Development Table 103. Sun Pharma Company Information Table 104. Sun Pharma Business Overview Table 105. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Sun Pharma Aminoglycosides Antibiotics Product Portfolio Table 107. Sun Pharma Recent Development Table 108. Hikma Company Information Table 109. Hikma Business Overview Table 110. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Hikma Aminoglycosides Antibiotics Product Portfolio Table 112. Hikma Recent Development Table 113. Lannett Company Company Information Table 114. Lannett Company Business Overview Table 115. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Lannett Company Aminoglycosides Antibiotics Product Portfolio Table 117. Lannett Company Recent Development Table 118. North America Aminoglycosides Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Aminoglycosides Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 121. North America Aminoglycosides Antibiotics Sales by Type (2027-2032) & (M Units) Table 122. North America Aminoglycosides Antibiotics Sales Price by Type (2021-2026) & (USD/Unit) Table 123. North America Aminoglycosides Antibiotics Sales Price by Type (2027-2032) & (USD/Unit) Table 124. North America Aminoglycosides Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Aminoglycosides Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 127. North America Aminoglycosides Antibiotics Sales by Application (2027-2032) & (M Units) Table 128. North America Aminoglycosides Antibiotics Sales Price by Application (2021-2026) & (USD/Unit) Table 129. North America Aminoglycosides Antibiotics Sales Price by Application (2027-2032) & (USD/Unit) Table 130. North America Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. North America Aminoglycosides Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. North America Aminoglycosides Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 134. North America Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 135. North America Aminoglycosides Antibiotics Sales by Country (2027-2032) & (M Units) Table 136. North America Aminoglycosides Antibiotics Sales Price by Country (2021-2026) & (USD/Unit) Table 137. North America Aminoglycosides Antibiotics Sales Price by Country (2027-2032) & (USD/Unit) Table 138. United States Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 139. Canada Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 140. Mexico Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 141. Europe Aminoglycosides Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Aminoglycosides Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 144. Europe Aminoglycosides Antibiotics Sales by Type (2027-2032) & (M Units) Table 145. Europe Aminoglycosides Antibiotics Sales Price by Type (2021-2026) & (USD/Unit) Table 146. Europe Aminoglycosides Antibiotics Sales Price by Type (2027-2032) & (USD/Unit) Table 147. Europe Aminoglycosides Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Aminoglycosides Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 150. Europe Aminoglycosides Antibiotics Sales by Application (2027-2032) & (M Units) Table 151. Europe Aminoglycosides Antibiotics Sales Price by Application (2021-2026) & (USD/Unit) Table 152. Europe Aminoglycosides Antibiotics Sales Price by Application (2027-2032) & (USD/Unit) Table 153. Europe Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Europe Aminoglycosides Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Europe Aminoglycosides Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 157. Europe Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 158. Europe Aminoglycosides Antibiotics Sales by Country (2027-2032) & (M Units) Table 159. Europe Aminoglycosides Antibiotics Sales Price by Country (2021-2026) & (USD/Unit) Table 160. Europe Aminoglycosides Antibiotics Sales Price by Country (2027-2032) & (USD/Unit) Table 161. Germany Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 162. France Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 163. U.K. Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 164. Italy Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 165. Russia Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 166. Spain Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 168. Switzerland Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 169. Sweden Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 170. Poland Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 171. China Aminoglycosides Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 172. China Aminoglycosides Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 173. China Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 174. China Aminoglycosides Antibiotics Sales by Type (2027-2032) & (M Units) Table 175. China Aminoglycosides Antibiotics Sales Price by Type (2021-2026) & (USD/Unit) Table 176. China Aminoglycosides Antibiotics Sales Price by Type (2027-2032) & (USD/Unit) Table 177. China Aminoglycosides Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 178. China Aminoglycosides Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 179. China Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 180. China Aminoglycosides Antibiotics Sales by Application (2027-2032) & (M Units) Table 181. China Aminoglycosides Antibiotics Sales Price by Application (2021-2026) & (USD/Unit) Table 182. China Aminoglycosides Antibiotics Sales Price by Application (2027-2032) & (USD/Unit) Table 183. Asia Aminoglycosides Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Aminoglycosides Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 186. Asia Aminoglycosides Antibiotics Sales by Type (2027-2032) & (M Units) Table 187. Asia Aminoglycosides Antibiotics Sales Price by Type (2021-2026) & (USD/Unit) Table 188. Asia Aminoglycosides Antibiotics Sales Price by Type (2027-2032) & (USD/Unit) Table 189. Asia Aminoglycosides Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Aminoglycosides Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 192. Asia Aminoglycosides Antibiotics Sales by Application (2027-2032) & (M Units) Table 193. Asia Aminoglycosides Antibiotics Sales Price by Application (2021-2026) & (USD/Unit) Table 194. Asia Aminoglycosides Antibiotics Sales Price by Application (2027-2032) & (USD/Unit) Table 195. Asia Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Aminoglycosides Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Aminoglycosides Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 199. Asia Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 200. Asia Aminoglycosides Antibiotics Sales by Country (2027-2032) & (M Units) Table 201. Asia Aminoglycosides Antibiotics Sales Price by Country (2021-2026) & (USD/Unit) Table 202. Asia Aminoglycosides Antibiotics Sales Price by Country (2027-2032) & (USD/Unit) Table 203. Japan Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 204. South Korea Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 205. India Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 206. Australia Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 207. Taiwan Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Aminoglycosides Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Aminoglycosides Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 212. SAMEA Aminoglycosides Antibiotics Sales by Type (2027-2032) & (M Units) Table 213. SAMEA Aminoglycosides Antibiotics Sales Price by Type (2021-2026) & (USD/Unit) Table 214. SAMEA Aminoglycosides Antibiotics Sales Price by Type (2027-2032) & (USD/Unit) Table 215. SAMEA Aminoglycosides Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Aminoglycosides Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 218. SAMEA Aminoglycosides Antibiotics Sales by Application (2027-2032) & (M Units) Table 219. SAMEA Aminoglycosides Antibiotics Sales Price by Application (2021-2026) & (USD/Unit) Table 220. SAMEA Aminoglycosides Antibiotics Sales Price by Application (2027-2032) & (USD/Unit) Table 221. SAMEA Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Aminoglycosides Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Aminoglycosides Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 225. SAMEA Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 226. SAMEA Aminoglycosides Antibiotics Sales by Country (2027-2032) & (M Units) Table 227. SAMEA Aminoglycosides Antibiotics Sales Price by Country (2021-2026) & (USD/Unit) Table 228. SAMEA Aminoglycosides Antibiotics Sales Price by Country (2027-2032) & (USD/Unit) Table 229. Brazil Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 230. Argentina Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 231. Chile Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 232. Colombia Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 233. Peru Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 235. Israel Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 236. UAE Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 237. Turkey Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 238. Iran Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 239. Egypt Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Aminoglycosides Antibiotics Distributors List Table 243. Aminoglycosides Antibiotics Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Aminoglycosides Antibiotics Image Figure 2. Global Aminoglycosides Antibiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aminoglycosides Antibiotics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Neomycin Image Figure 5. Tobramycin Image Figure 6. Gentamicin Image Figure 7. Amikacin Image Figure 8. Etimicin Image Figure 9. Others Image Figure 10. Global Aminoglycosides Antibiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Aminoglycosides Antibiotics Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Post Care Facility Image Figure 15. Government & Military Image Figure 16. Others Image Figure 17. Global Aminoglycosides Antibiotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Figure 19. Global Aminoglycosides Antibiotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Aminoglycosides Antibiotics Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2021-2032) Figure 22. Global Aminoglycosides Antibiotics Sales (2021-2032) & (M Units) Figure 23. Global Aminoglycosides Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 24. Global Aminoglycosides Antibiotics Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Aminoglycosides Antibiotics Sales YoY (2021-2032) & (M Units) Figure 26. Europe Aminoglycosides Antibiotics Sales YoY (2021-2032) & (M Units) Figure 27. China Aminoglycosides Antibiotics Sales YoY (2021-2032) & (M Units) Figure 28. Asia (Excluding China) Aminoglycosides Antibiotics Sales YoY (2021-2032) & (M Units) Figure 29. South America, Middle East and Africa Aminoglycosides Antibiotics Sales YoY (2021-2032) & (M Units) Figure 30. Global Aminoglycosides Antibiotics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Aminoglycosides Antibiotics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Aminoglycosides Antibiotics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Aminoglycosides Antibiotics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2021-2032) Figure 36. Global Aminoglycosides Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 37. Global Aminoglycosides Antibiotics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Aminoglycosides Antibiotics Sales Market Share by Type (2021-2032) Figure 39. Global Aminoglycosides Antibiotics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Aminoglycosides Antibiotics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2021-2032) Figure 42. Global Aminoglycosides Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 43. Global Aminoglycosides Antibiotics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Aminoglycosides Antibiotics Sales Market Share by Application (2021-2032) Figure 45. North America Aminoglycosides Antibiotics Revenue Share by Type (2021-2032) Figure 46. North America Aminoglycosides Antibiotics Sales Share by Type (2021-2032) Figure 47. North America Aminoglycosides Antibiotics Revenue Share by Application (2021-2032) Figure 48. North America Aminoglycosides Antibiotics Sales Share by Application (2021-2032) Figure 49. North America Aminoglycosides Antibiotics Revenue Share by Country (2021-2032) Figure 50. North America Aminoglycosides Antibiotics Sales Share by Country (2021-2032) Figure 51. Europe Aminoglycosides Antibiotics Revenue Share by Type (2021-2032) Figure 52. Europe Aminoglycosides Antibiotics Sales Share by Type (2021-2032) Figure 53. Europe Aminoglycosides Antibiotics Revenue Share by Application (2021-2032) Figure 54. Europe Aminoglycosides Antibiotics Sales Share by Application (2021-2032) Figure 55. Europe Aminoglycosides Antibiotics Revenue Share by Country (2021-2032) Figure 56. Europe Aminoglycosides Antibiotics Sales Share by Country (2021-2032) Figure 57. China Aminoglycosides Antibiotics Revenue Share by Type (2021-2032) Figure 58. China Aminoglycosides Antibiotics Sales Share by Type (2021-2032) Figure 59. China Aminoglycosides Antibiotics Revenue Share by Application (2021-2032) Figure 60. China Aminoglycosides Antibiotics Sales Share by Application (2021-2032) Figure 61. Asia Aminoglycosides Antibiotics Revenue Share by Type (2021-2032) Figure 62. Asia Aminoglycosides Antibiotics Sales Share by Type (2021-2032) Figure 63. Asia Aminoglycosides Antibiotics Revenue Share by Application (2021-2032) Figure 64. Asia Aminoglycosides Antibiotics Sales Share by Application (2021-2032) Figure 65. Asia Aminoglycosides Antibiotics Revenue Share by Country (2021-2032) Figure 66. Asia Aminoglycosides Antibiotics Sales Share by Country (2021-2032) Figure 67. SAMEA Aminoglycosides Antibiotics Revenue Share by Type (2021-2032) Figure 68. SAMEA Aminoglycosides Antibiotics Sales Share by Type (2021-2032) Figure 69. SAMEA Aminoglycosides Antibiotics Revenue Share by Application (2021-2032) Figure 70. SAMEA Aminoglycosides Antibiotics Sales Share by Application (2021-2032) Figure 71. SAMEA Aminoglycosides Antibiotics Revenue Share by Country (2021-2032) Figure 72. SAMEA Aminoglycosides Antibiotics Sales Share by Country (2021-2032) Figure 73. Aminoglycosides Antibiotics Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Aminoglycosides Antibiotics Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Etimicin
  • Others
Applications
  • Hospital
  • Clinic
  • Post Care Facility
  • Government & Military
  • Others
Companies covered
  • Jemicare
  • Teva
  • Novartis
  • Fangyuan-pharma
  • Aike Pharmaceutical
  • Cipla
  • Pfizer
  • Fresenius Kabi
  • Sun Pharma
  • Hikma
  • Lannett Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Aminoglycosides Antibiotics Market by Type
  3. 1.2.1 Global Aminoglycosides Antibiotics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Neomycin
  5. 1.2.3 Tobramycin
  6. 1.2.4 Gentamicin
  7. 1.2.5 Amikacin
  8. 1.2.6 Etimicin
  9. 1.2.7 Others
  10. 1.3 Aminoglycosides Antibiotics Market by Application
  11. 1.3.1 Global Aminoglycosides Antibiotics Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Clinic
  14. 1.3.4 Post Care Facility
  15. 1.3.5 Government & Military
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Aminoglycosides Antibiotics Market Dynamics
  1. 2.1 Aminoglycosides Antibiotics Industry Trends
  2. 2.2 Aminoglycosides Antibiotics Industry Drivers
  3. 2.3 Aminoglycosides Antibiotics Industry Opportunities and Challenges
  4. 2.4 Aminoglycosides Antibiotics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Aminoglycosides Antibiotics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Aminoglycosides Antibiotics Revenue by Region
  3. 3.2.1 Global Aminoglycosides Antibiotics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Aminoglycosides Antibiotics Revenue by Region (2021-2026)
  5. 3.2.3 Global Aminoglycosides Antibiotics Revenue by Region (2027-2032)
  6. 3.2.4 Global Aminoglycosides Antibiotics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Aminoglycosides Antibiotics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Aminoglycosides Antibiotics Sales by Region
  9. 3.4.1 Global Aminoglycosides Antibiotics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Aminoglycosides Antibiotics Sales by Region (2021-2026)
  11. 3.4.3 Global Aminoglycosides Antibiotics Sales by Region (2027-2032)
  12. 3.4.4 Global Aminoglycosides Antibiotics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Aminoglycosides Antibiotics Revenue by Manufacturers
  2. 4.1.1 Global Aminoglycosides Antibiotics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Aminoglycosides Antibiotics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Aminoglycosides Antibiotics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Aminoglycosides Antibiotics Sales by Manufacturers
  6. 4.2.1 Global Aminoglycosides Antibiotics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Aminoglycosides Antibiotics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Aminoglycosides Antibiotics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Aminoglycosides Antibiotics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Aminoglycosides Antibiotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Aminoglycosides Antibiotics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Aminoglycosides Antibiotics Manufacturers, Product Type & Application
  13. 4.7 Global Aminoglycosides Antibiotics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Aminoglycosides Antibiotics Market CR5 and HHI
  16. 4.8.2 2025 Aminoglycosides Antibiotics Tier 1, Tier 2, and Tier 3
5 Aminoglycosides Antibiotics Market by Type
  1. 5.1 Global Aminoglycosides Antibiotics Revenue by Type
  2. 5.1.1 Global Aminoglycosides Antibiotics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Aminoglycosides Antibiotics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Aminoglycosides Antibiotics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Aminoglycosides Antibiotics Sales by Type
  6. 5.2.1 Global Aminoglycosides Antibiotics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Aminoglycosides Antibiotics Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Aminoglycosides Antibiotics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Aminoglycosides Antibiotics Price by Type
6 Aminoglycosides Antibiotics Market by Application
  1. 6.1 Global Aminoglycosides Antibiotics Revenue by Application
  2. 6.1.1 Global Aminoglycosides Antibiotics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Aminoglycosides Antibiotics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Aminoglycosides Antibiotics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Aminoglycosides Antibiotics Sales by Application
  6. 6.2.1 Global Aminoglycosides Antibiotics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Aminoglycosides Antibiotics Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Aminoglycosides Antibiotics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Aminoglycosides Antibiotics Price by Application
7 Company Profiles
  1. 7.1 Jemicare
  2. 7.1.1 Jemicare Company Information
  3. 7.1.2 Jemicare Business Overview
  4. 7.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Jemicare Aminoglycosides Antibiotics Product Portfolio
  6. 7.1.5 Jemicare Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Aminoglycosides Antibiotics Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Aminoglycosides Antibiotics Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Fangyuan-pharma
  20. 7.4.1 Fangyuan-pharma Company Information
  21. 7.4.2 Fangyuan-pharma Business Overview
  22. 7.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio
  24. 7.4.5 Fangyuan-pharma Recent Developments
  25. 7.5 Aike Pharmaceutical
  26. 7.5.1 Aike Pharmaceutical Company Information
  27. 7.5.2 Aike Pharmaceutical Business Overview
  28. 7.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio
  30. 7.5.5 Aike Pharmaceutical Recent Developments
  31. 7.6 Cipla
  32. 7.6.1 Cipla Company Information
  33. 7.6.2 Cipla Business Overview
  34. 7.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Cipla Aminoglycosides Antibiotics Product Portfolio
  36. 7.6.5 Cipla Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Aminoglycosides Antibiotics Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Fresenius Kabi
  44. 7.8.1 Fresenius Kabi Company Information
  45. 7.8.2 Fresenius Kabi Business Overview
  46. 7.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio
  48. 7.8.5 Fresenius Kabi Recent Developments
  49. 7.9 Sun Pharma
  50. 7.9.1 Sun Pharma Company Information
  51. 7.9.2 Sun Pharma Business Overview
  52. 7.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sun Pharma Aminoglycosides Antibiotics Product Portfolio
  54. 7.9.5 Sun Pharma Recent Developments
  55. 7.10 Hikma
  56. 7.10.1 Hikma Company Information
  57. 7.10.2 Hikma Business Overview
  58. 7.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hikma Aminoglycosides Antibiotics Product Portfolio
  60. 7.10.5 Hikma Recent Developments
  61. 7.11 Lannett Company
  62. 7.11.1 Lannett Company Company Information
  63. 7.11.2 Lannett Company Business Overview
  64. 7.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Lannett Company Aminoglycosides Antibiotics Product Portfolio
  66. 7.11.5 Lannett Company Recent Developments
8 North America
  1. 8.1 North America Aminoglycosides Antibiotics Market Size by Type
  2. 8.1.1 North America Aminoglycosides Antibiotics Revenue by Type (2021-2032)
  3. 8.1.2 North America Aminoglycosides Antibiotics Sales by Type (2021-2032)
  4. 8.1.3 North America Aminoglycosides Antibiotics Price by Type (2021-2032)
  5. 8.2 North America Aminoglycosides Antibiotics Market Size by Application
  6. 8.2.1 North America Aminoglycosides Antibiotics Revenue by Application (2021-2032)
  7. 8.2.2 North America Aminoglycosides Antibiotics Sales by Application (2021-2032)
  8. 8.2.3 North America Aminoglycosides Antibiotics Price by Application (2021-2032)
  9. 8.3 North America Aminoglycosides Antibiotics Market Size by Country
  10. 8.3.1 North America Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Aminoglycosides Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Aminoglycosides Antibiotics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Aminoglycosides Antibiotics Market Size by Type
  2. 9.1.1 Europe Aminoglycosides Antibiotics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Aminoglycosides Antibiotics Sales by Type (2021-2032)
  4. 9.1.3 Europe Aminoglycosides Antibiotics Price by Type (2021-2032)
  5. 9.2 Europe Aminoglycosides Antibiotics Market Size by Application
  6. 9.2.1 Europe Aminoglycosides Antibiotics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Aminoglycosides Antibiotics Sales by Application (2021-2032)
  8. 9.2.3 Europe Aminoglycosides Antibiotics Price by Application (2021-2032)
  9. 9.3 Europe Aminoglycosides Antibiotics Market Size by Country
  10. 9.3.1 Europe Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Aminoglycosides Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Aminoglycosides Antibiotics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Aminoglycosides Antibiotics Market Size by Type
  2. 10.1.1 China Aminoglycosides Antibiotics Revenue by Type (2021-2032)
  3. 10.1.2 China Aminoglycosides Antibiotics Sales by Type (2021-2032)
  4. 10.1.3 China Aminoglycosides Antibiotics Price by Type (2021-2032)
  5. 10.2 China Aminoglycosides Antibiotics Market Size by Application
  6. 10.2.1 China Aminoglycosides Antibiotics Revenue by Application (2021-2032)
  7. 10.2.2 China Aminoglycosides Antibiotics Sales by Application (2021-2032)
  8. 10.2.3 China Aminoglycosides Antibiotics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Aminoglycosides Antibiotics Market Size by Type
  2. 11.1.1 Asia Aminoglycosides Antibiotics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Aminoglycosides Antibiotics Sales by Type (2021-2032)
  4. 11.1.3 Asia Aminoglycosides Antibiotics Price by Type (2021-2032)
  5. 11.2 Asia Aminoglycosides Antibiotics Market Size by Application
  6. 11.2.1 Asia Aminoglycosides Antibiotics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Aminoglycosides Antibiotics Sales by Application (2021-2032)
  8. 11.2.3 Asia Aminoglycosides Antibiotics Price by Application (2021-2032)
  9. 11.3 Asia Aminoglycosides Antibiotics Market Size by Country
  10. 11.3.1 Asia Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Aminoglycosides Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Aminoglycosides Antibiotics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Aminoglycosides Antibiotics Market Size by Type
  2. 12.1.1 SAMEA Aminoglycosides Antibiotics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Aminoglycosides Antibiotics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Aminoglycosides Antibiotics Price by Type (2021-2032)
  5. 12.2 SAMEA Aminoglycosides Antibiotics Market Size by Application
  6. 12.2.1 SAMEA Aminoglycosides Antibiotics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Aminoglycosides Antibiotics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Aminoglycosides Antibiotics Price by Application (2021-2032)
  9. 12.3 SAMEA Aminoglycosides Antibiotics Market Size by Country
  10. 12.3.1 SAMEA Aminoglycosides Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Aminoglycosides Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Aminoglycosides Antibiotics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Aminoglycosides Antibiotics Value Chain Analysis
  2. 13.1.1 Aminoglycosides Antibiotics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Aminoglycosides Antibiotics Production Mode & Process
  6. 13.2 Aminoglycosides Antibiotics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Aminoglycosides Antibiotics Distributors
  9. 13.2.3 Aminoglycosides Antibiotics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst